Skip to main content
Premium Trial:

Request an Annual Quote

Applied BioCode Licenses Patents to Molecular Devices

NEW YORK (GenomeWeb) – Applied BioCode said today that it has signed a license and supply agreement for its barcoded magnetic bead (BMB) technology with bioanalytics firm Molecular Devices.

The deal gives Molecular Devices access to specific Applied BioCode BMB patents for use on its own microplate reading devices within the life sciences, food and beverage research, and environmental testing markets. Further details of the agreement were not disclosed.

“Our barcoded magnetic bead technology combined with Molecular Devices microplate reading devices will expand its capabilities from single to multiple analyte tests and create a formidable force for multiplexed testing within these markets," Winston Ho, president of Applied BioCode, said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more